Johnson & Johnson to pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of the...
Read moreJohnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of the...
Read moreJust ahead of its blowout first-quarter earnings report on April 25, Google laid off at least 200 employees from its “Core” teams,...
Read morePeloton announced Thursday that CEO Barry McCarthy will be stepping down and the company will lay off 15% of its staff...
Read moreArcade giant Dave & Buster’s is set to allow adults 18 and older to place real-time bets with friends on...
Read moreStrong demand and tight supply continue to push home values higher, even though mortgage rates are now moving higher again....
Read moreDisclaimer: Thefinancialhorizons.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Disclaimer: Thefinancialhorizons.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.